EFICACY AND SAFETY OF AN ORAL LIVE ATENUATED HUMAN ROTAVIRUS VACCINE AGAINST ROTAVIRUS GASTROENTERITIS DURING THE FIRST 2 YEARS OF LIFE IN LATIN AMERICAN INFANTS: A RANDOMISED, DOUBLE-BLING, PLACEBO-CONTROLLED PHASE III STUDY